Utility of Protein Markers in COVID-19 Patients DOI Open Access
Alicia López-Biedma, María Ángeles Onieva-García, Desirée Martín‐García

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(2), С. 653 - 653

Опубликована: Янв. 14, 2025

COVID-19 has been a challenge at the healthcare level not only in early stages of pandemic, but also subsequent appearance long-term COVID-19. Several investigations have attempted to identify proteomic biomarkers an attempt improve clinical care, guide treatment and predict possible patient outcomes. Proteins such as C-reactive protein (CRP) or interleukin 6 (IL-6) are clear markers severe disease, many others proposed that could help risk stratification prediction specific complications. This review aims bring together most relevant studies this regard, providing information notable relation found date.

Язык: Английский

Utility of Protein Markers in COVID-19 Patients DOI Open Access
Alicia López-Biedma, María Ángeles Onieva-García, Desirée Martín‐García

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(2), С. 653 - 653

Опубликована: Янв. 14, 2025

COVID-19 has been a challenge at the healthcare level not only in early stages of pandemic, but also subsequent appearance long-term COVID-19. Several investigations have attempted to identify proteomic biomarkers an attempt improve clinical care, guide treatment and predict possible patient outcomes. Proteins such as C-reactive protein (CRP) or interleukin 6 (IL-6) are clear markers severe disease, many others proposed that could help risk stratification prediction specific complications. This review aims bring together most relevant studies this regard, providing information notable relation found date.

Язык: Английский

Процитировано

0